Pirarubicin inhibits multidrug-resistant osteosarcoma cell proliferation through induction of G2/M phase cell cycle arrest-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pirarubicin inhibits multidrug-resistant osteosarcoma cell proliferation through induction of G2/M phase cell cycle arrest

Published:2012-05-14 Issue:6 Volume:33 Page:832-838
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Zheng Shui-er,Xiong Sang,Lin Feng,Qiao Guang-lei,Feng Tao,Shen Zan,Min Da-liu,Zhang Chun-ling,Yao Yang

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.nature.com/articles/aps201220.pdf

Reference38 articles.

1. Chou AJ, Gorlick R . Chemotherapy resistance in osteosarcoma current challenges and future directions. Expert Rev Anticancer Ther 2006; 6: 1075–85.

2. Hawkins DS, Arndt CA . Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy. Cancer 2003; 98: 2447–56.

3. Chou AJ, Merola PR, Wexler LH, Gorlick RG, Vyas YM, Healey JH, et al. Treatment of osteosarcoma at first recurrence after contemporary therapy: the memorial sloan-kettering cancer center experience. Cancer 2005; 104: 2214–21.

4. Shinozaki T, Watanabe H, Yanagawa T, Shirakura K, Takagishi K . Pirarubicin-based versus doxorubicin-based osteosarcoma chemotherapy. Ann Pharmacother 2002; 36: 996–9.

5. Li JJ, Di GH, Tang LC, Yu KD, Hu Z, Liu GY, et al. Adjuvant therapy of breast cancer with pirarubicin versus epirubicin in combination with cyclophosphamide and 5-fluorouracil. Breast J 2011; 17: 657–60.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Deubiquitinating Enzymes in Primary Bone Cancer;Molecular Biotechnology;2024-08-23

2. Perfusion drugs for non‑muscle invasive bladder cancer (Review);Oncology Letters;2024-04-15

3. Canagliflozin is a potential cardioprotective drug but exerts no significant effects on pirarubicin‑induced cardiotoxicity in rats;Molecular Medicine Reports;2021-08-05

4. Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway;Phytomedicine;2021-07

5. BF12, a Novel Benzofuran, Exhibits Antitumor Activity by Inhibiting Microtubules and the PI3K/Akt/mTOR Signaling Pathway in Human Cervical Cancer Cells;Chemistry & Biodiversity;2020-02-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3